Literature DB >> 21949040

Diagnosis and management of isolated subsegmental pulmonary embolism: review and assessment of the options.

Paul D Stein1, Lawrence R Goodman, Russell D Hull, James E Dalen, Fadi Matta.   

Abstract

We assessed the potential safety of withholding treatment of pulmonary embolism (PE) limited to subsegmental branches. Literature review showed that untreated patients with mostly subsegmental PE had no fatal recurrences in 1 to 3 months and no nonfatal recurrences of PE in 3 months. Patients with suspected PE who had nondiagnostic ventilation/perfusion lung scans, adequate cardiorespiratory reserve or low or moderate clinical probability, and negative serial noninvasive leg tests were shown not to require treatment. It appears safe, therefore, to withhold treatment of subsegmental PE providing (1) pulmonary-respiratory reserve is good; (2) no evidence of deep venous thrombosis (DVT) on serial testing; (3) major risk factor for PE was transient and no longer present; (4) no history of central venous catheterization or atrial fibrillation; and (5) willingness to return for serial venous ultrasound. After fully informing patients, some may choose to be treated and some may choose not to be treated.

Entities:  

Mesh:

Year:  2011        PMID: 21949040     DOI: 10.1177/1076029611422363

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  26 in total

1.  Subsegmental pulmonary embolism: is the emperor still naked?

Authors:  Maurizio Zompatori; Domenico Attinà; Fabio Niro; Gualtiero Palareti
Journal:  Radiol Med       Date:  2013-07-15       Impact factor: 3.469

Review 2.  Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions.

Authors:  Donald G Benson; Mark L Schiebler; Michael D Repplinger; Christopher J François; Thomas M Grist; Scott B Reeder; Scott K Nagle
Journal:  Br J Radiol       Date:  2017-04-12       Impact factor: 3.039

3.  Unsuspected pulmonary thromboemboli: a continuing clinical challenge.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2013

4.  High Prevalence of Persistent Breathlessness Following Sub-Massive Pulmonary Embolism in Patients Presenting to a Large Regional Hospital in South Wales.

Authors:  Patrick Flood-Page
Journal:  Turk Thorac J       Date:  2020-11-01

Review 5.  Symptomatic subsegmental pulmonary embolism: to treat or not to treat?

Authors:  Marc Carrier; Fredrikus A Klok
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 6.  Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program.

Authors:  Scott K Nagle; Mark L Schiebler; Michael D Repplinger; Christopher J François; Karl K Vigen; Rajkumar Yarlagadda; Thomas M Grist; Scott B Reeder
Journal:  Eur J Radiol       Date:  2015-12-29       Impact factor: 3.528

7.  Can the use of an age-adjusted D-dimer cut-off value help in our diagnosis of suspected pulmonary embolism? .

Authors:  Jonathan Dutton; Martin Dachsel; Rachel Crane
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

Review 8.  Imaging of acute pulmonary embolism.

Authors:  Maria Komissarova; Suzanne Chong; Kirk Frey; Baskaran Sundaram
Journal:  Emerg Radiol       Date:  2012-11-14

9.  Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year.

Authors:  Mark L Schiebler; Scott K Nagle; Christopher J François; Michael D Repplinger; Azita G Hamedani; Karl K Vigen; Rajkumar Yarlagadda; Thomas M Grist; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-04-01       Impact factor: 4.813

10.  Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial.

Authors:  Yonathan Freund; Marine Cachanado; Adeline Aubry; Charlotte Orsini; Pierre-Alexis Raynal; Anne-Laure Féral-Pierssens; Sandrine Charpentier; Florence Dumas; Nacera Baarir; Jennifer Truchot; Thibaut Desmettre; Karim Tazarourte; Sebastien Beaune; Agathe Leleu; Mehdi Khellaf; Mathias Wargon; Ben Bloom; Alexandra Rousseau; Tabassome Simon; Bruno Riou
Journal:  JAMA       Date:  2018-02-13       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.